Published on
June 15, 2026
- 09:00 GMT
FDA Clears First-in-Indication Cell Therapy Trial for Chronic Traumatic Encephalopathy — for the Warriors Who Carry CTE
FDA Authorizes TriCelX’s XytriX™ to Enter the Clinic in CTE—the First Cell Therapy Ever Studied in a Disease That Has Devastated Navy SEALs & NFL Players Alike FRISCO, TX, UNITED STATES, June 15, 2026 /EINPresswire.com/ -- TriCelX, Inc. today …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
